I wonder how Sinemet can be any different from any other co-careldopa as it has the exact same ingredients
My local pharmacist suppliers changed the packaging of my generic co-careldopa from a blister for each tablet into child lock phials, a cost cutting exercise and not a clever thing to do especially for a lot of people to access them.
Had to change my pharmacist to Boots, and request Sinemet as they still do the single tablet in blisters
Sometimes the formulation is different and it gets absorbed at a slightly different rate so people ca notice a difference with the same dose. Most people don’t, so generics are fine in general. Parkinon’s meds shouldn’t come in child locks, my come in a screw top vial but are easy to open.
Sinemet (co-careldopa) and madopar (co-beneldopa), otherwise known as L-dopa, are the single most effective treatments for Parkinson’s disease. The majority of people have no problems with taking them (early on) and receive significant benefits. A few people have side effects and require medication changes. As time goes on the medications become less effective, and yes there are more side effects, but the benefits remain. We should not scare newly diagnosed people away from drugs that will give a much better quality of life on the off chance they might get side effects.
1 Like